USP17L2 and breast carcinoma: Overall, our study demonstrates that the CDK4/6–DUB3 axis functions as an important regulatory mechanism of breast cancer metastasis and provides a potential therapeutic approach in the management of breast cancer metastasis (Fig. 6h).